Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
06/18

DJ Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Edwards Lifesciences Corp. $(EW)$ slid 2.14% to $86.68 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,420.10 and Dow Jones Industrial Average falling 0.98% to 51,492.55.

The stock's fall snapped a two-day winning streak.

Edwards Lifesciences Corp. closed 3.26% below its 52-week high of $89.60, which the company reached on June 16th.

Despite its losses, the stock outperformed some of its competitors Wednesday, as Abbott Laboratories $(ABT)$ fell 2.34% to $88.50, Medtronic PLC $(MDT)$ fell 3.91% to $78.14, and Stryker Corp. $(SYK)$ fell 3.04% to $301.14.

Trading volume (5.0 M) remained 245,620 below its 50-day average volume of 5.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

June 17, 2026 16:50 ET (20:50 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10